Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert Martin Grotzfeld is active.

Publication


Featured researches published by Robert Martin Grotzfeld.


Science | 1996

Reversible Encapsulation of Disc-Shaped Guests by a Synthetic, Self-Assembled Host

Robert Martin Grotzfeld; Neil R. Branda; Julius Rebek

Here, the synthesis of a bowl-shaped molecule is described and evidence of its reversible dimerization by means of hydrogen bonds is presented. The dimer features a flattened spherical cavity of peculiar symmetry and acts as a host for the encapsulation of guest molecules of complementary shape. Encapsulation of aromatic guests in chloroform solution and of cyclohexane in p-xylene solution was demonstrated by nuclear magnetic resonance experiments. The passage of guests into and out of the cavity is slow and occurs on a time scale of hours. The system was used to explore the effects of size, shape, and solvation on molecular recognition coupled with assembly.


Journal of the American Chemical Society | 2010

Binding or bending: distinction of allosteric Abl kinase agonists from antagonists by an NMR-based conformational assay.

Wolfgang Jahnke; Robert Martin Grotzfeld; Xavier Francois Andre Pelle; André Strauss; Gabriele Fendrich; Sandra W. Cowan-Jacob; Simona Cotesta; Doriano Fabbro; Pascal Furet; Jürgen Mestan; Andreas Marzinzik

Allosteric inhibitors of Bcr-Abl have emerged as a novel therapeutic option for the treatment of CML. Using fragment-based screening, a search for novel Abl inhibitors that bind to the myristate pocket was carried out. Here we show that not all myristate ligands are functional inhibitors, but that the conformational state of C-terminal helix_I is a structural determinant for functional activity. We present an NMR-based conformational assay to monitor the conformation of this crucial helix_I and show that myristate ligands that bend helix_I are functional antagonists, whereas ligands that bind to the myristate pocket but do not induce this conformational change are kinase agonists. Activation of c-Abl by allosteric agonists has been confirmed in a biochemical assay.


Archive | 1995

Control of Self-Assembly by Acid-Base Chemistry

Robert Martin Grotzfeld; Neil R. Branda; Carlos Valdés; Julius Rebek

Recent progress in the field of molecular recognition has led to the introduction of self- assembling systems of varying complexity. A simple system in which two identical subunits are held together by hydrogen bonds has previously been developed.[1] Since then, two similar capsule-forming compounds have been synthesized (figure 1).[2] These are based on p-N,N-dimethylaminophenyl- or carbethoxysubstituted glycolurils which are readily available from the corresponding benzil and dihydroxytartaric acid (disodium salt) respectively by condensation with urea. By using other alcohols for the esterification such as isoamyl alcohol or cyclohexanol, soluble glycolurils (e.g. in pyridine or dioxane) are obtained which are promising candidates for the synthesis of more complex self-assembling systems. Alkylation of the glycolurils la and lb with 1,2,4,5-tetrakisbromomethylbenzene gave the new self-complementary compounds 2a and 2b, both showing enhanced solubility in organic solvents. As expected, both compounds can encapsulate methane, ethane, and ethylene as evidenced by 1H-NMR.


Journal of the American Chemical Society | 1995

Control of Self-Assembly and Reversible Encapsulation of Xenon in a Self-Assembling Dimer by Acid-Base Chemistry

Neil R. Branda; Robert Martin Grotzfeld; Carlos Valdés; Julius Rebek


Archive | 2017

derivados de benzamida para a inibição da atividade de abl1, abl2 e bcr-abl1

Andreas Marzinzik; Bahaa Salem; Darryl Brynley Jones; Joseph Schoepfer; Pascal Furet; Paul W. Manley; Robert Martin Grotzfeld; Stephanie Dodd; Wolfgang Jahnke; Xavier Francois Andre Pelle


Archive | 2017

compostos e composições para inibir a atividade de abl1, abl2 e bcr-abl1

Andreas Marzinzik; Bahaa Salem; Darryl Brynley Jones; Joseph Schoepfer; Pascal Furet; Paul W. Manley; Robert Martin Grotzfeld; Saliha Moussaoui; Wolfgang Jahnke; Xavier Francois Andre Pelle


Archive | 2015

Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer.

Pascal Furet; Stephanie Dodd; Robert Martin Grotzfeld; Darryl Brynley Jones; Paul W. Manley; Andreas Marzinzik; Xavier Francois Andre Pelle; Bahaa Salem; Joseph Schoepfer; Wolfgang Jahnke


Archive | 2014

INHIBIDORES DE LA PROLIFERACIÓN CELULAR Y CONJUGADOS DE LOS MISMOS

Paul A. Barsanti; Sylvie Chamoin; Lionel Doumampouom-Metoul; Bernhard Hubert Geierstanger; Robert Martin Grotzfeld; Stephanie Guerro-Lagasse; Darryl Brynley Jones; Alexei Karpov; Marc Lafrance; Cristina Nieto-Oberhuber; Weijia Ou; Grazia Piizzi


Archive | 2013

COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE LA ABL1, ABL2 Y BCR-ABL1

Stephanie Dodd; Pascal Furet; Robert Martin Grotzfeld; Darryl Brynley Jones; Paul W. Manley; Andreas Marzinzik; Xavier Francois Andre Pelle; Bahaa Salem; Joseph Schoepfer


Archive | 2013

Composés et compositions pour l'inhibition de l'activité abl1, abl2 et bcr-abl1

Pascal Furet; Robert Martin Grotzfeld; Darryl Brynley Jones; Paul W. Manley; Andreas Marzinzik; Saliha Moussaoui; Xavier Francois Andre Pelle; Bahaa Salem; Joseph Schoepfer

Collaboration


Dive into the Robert Martin Grotzfeld's collaboration.

Researchain Logo
Decentralizing Knowledge